Very true, it doesn’t help when we are looking a
Post# of 155582
(Total Views: 643)
Posted On: 07/10/2020 12:32:30 AM
Very true, it doesn’t help when we are looking at other companies and we are all here because we know what we have is better.
I think I’m running out of comments so I’ll ask this here.
I know I won’t get a straight answer, but Dr NP brought up unmet medical need for the severe trial, however he appeared to brush over the mild to moderate? I’ll have to rewatch.
Anyways my question is could we get EAU on the Phase 2 MM trial then approval for phase 3? I don’t think that’s a bad thing and more likely? I think NP basically said he doesn’t know. Maybe someone can shed some light on possible outcomes again. Having a hard time putting this together.
Also does this mean we will still be able to get a readout on the severe trial as will as the MM at the same time, thus the request for the information to be released.
Some clarification would be great.
I think I’m running out of comments so I’ll ask this here.
I know I won’t get a straight answer, but Dr NP brought up unmet medical need for the severe trial, however he appeared to brush over the mild to moderate? I’ll have to rewatch.
Anyways my question is could we get EAU on the Phase 2 MM trial then approval for phase 3? I don’t think that’s a bad thing and more likely? I think NP basically said he doesn’t know. Maybe someone can shed some light on possible outcomes again. Having a hard time putting this together.
Also does this mean we will still be able to get a readout on the severe trial as will as the MM at the same time, thus the request for the information to be released.
Some clarification would be great.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com